This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.

You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/england/tees/6260543.stm

The article has changed 4 times. There is an RSS feed of changes available.

Version 0 Version 1
Cancer patient considers new home Cancer patient considers new home
(about 1 hour later)
A cancer patient is planning to move from England to Scotland because he says it is the only way he can get a drug which could prolong his life. A cancer patient says he is planning to move from England to Scotland to be sure of getting a drug which may prolong his life on the NHS.
George King, from Skelton, Teeside has a rare terminal form of bone cancer.George King, from Skelton, Teeside has a rare terminal form of bone cancer.
It is currently in remission, but when it returns he wants the treatment which may extend his life - the drug Velcade.It is currently in remission, but when it returns he wants the treatment which may extend his life - the drug Velcade.
The body which recommends which drugs the NHS should prescribe says it should not be available to patients in his position, but in Scotland it is.The body which recommends which drugs the NHS should prescribe says it should not be available to patients in his position, but in Scotland it is.
The National Institute for Health and Clinical Excellence (Nice), has argued that Velcade, otherwise known as Bortezomib, is too expensive when measured against how long it can prolong life. In a preliminary ruling, the National Institute for Health and Clinical Excellence (Nice), argued that Velcade, otherwise known as Bortezomib, is too expensive when measured against how long it can prolong life.
Nice still has to issue its final ruling on the matter.
Are we saying that an English or Welsh life isn't worth the same as a Scottish life? George KingAre we saying that an English or Welsh life isn't worth the same as a Scottish life? George King
A single course of treatment can cost around £25,000, and for patients in the later stages of Multiple Myeloma, such as Mr King, it can cost as much as £107,000 for each year of life gained. A single course of treatment can cost around £25,000, and for patients in the later stages of Multiple Myeloma, such as Mr King, it can cost as much as £107,000 a year.
However, in Scotland the situation is different.However, in Scotland the situation is different.
Velcade is available there because the Scottish equivalent of Nice, the Scottish Medicines Consortium, said it should be prescribed by the health service.Velcade is available there because the Scottish equivalent of Nice, the Scottish Medicines Consortium, said it should be prescribed by the health service.
Mr King said it was wrong he should have to move over the border.Mr King said it was wrong he should have to move over the border.
He said: "Are we saying that an English or Welsh life isn't worth the same as a Scottish life?He said: "Are we saying that an English or Welsh life isn't worth the same as a Scottish life?
"You know, it's comparable. We live in the United Kingdom; we do not live in two separate countries.""You know, it's comparable. We live in the United Kingdom; we do not live in two separate countries."
An appeal has been launched against the guidance issued by Nice, and is due to be heard next month. An appeal is due to be heard next month before the appraisal process is complete and Nice publishes its final guidance.